Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.86 USD | -1.62% | -6.00% | -16.02% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.02% | 3.23B | |
+4.99% | 32.18B | |
+14.14% | 7.33B | |
+22.93% | 3.83B | |
-25.48% | 1.25B | |
-36.14% | 1.12B | |
-0.15% | 912M | |
-35.42% | 859M | |
-24.21% | 856M | |
-18.47% | 661M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- BTIG Adjusts Evolent Health's Price Target to $50 From $45, Reiterates Buy Rating